Abstract

In recent years, Metal-Organic Frameworks (MOFs) have attracted a growing interest for biomedical applications. The design of MOFs should take into consideration the subtle balance between stability and biodegradability. However, only few studies have focused on the MOFs’ stability in physiological media and their degradation mechanism. Here, we investigate the degradation of mesoporous iron (III) carboxylate MOFs, which are among the most employed MOFs for drug delivery, by a set of complementary methods. In situ AFM allowed monitoring with nanoscale resolution the morphological, dimensional, and mechanical properties of a series of MOFs in phosphate buffer saline and in real time. Depending on the synthetic route, the external surface presented either well-defined crystalline planes or initial defects, which influenced the degradation mechanism of the particles. Moreover, MOF stability was investigated under different pH conditions, from acidic to neutral. Interestingly, despite pronounced erosion, especially at neutral pH, the dimensions of the crystals were unchanged. It was revealed that the external surfaces of MOF crystals rapidly respond to in situ changes of the composition of the media they are in contact with. These observations are of a crucial importance for the design of nanosized MOFs for drug delivery applications.

Highlights

  • Studies showed that the surface of large crystals has well-defined crystalline planes and might possess small crystal defects where degradawell-defined planes and might possess small defects wherematerial

  • The nanoMOFs degraded without noticeable size modification

  • This study highlights the fast response of Metal-Organic Frameworks (MOFs)

Read more

Summary

Introduction

The nanosized MOFs (nanoMOFs) have emerged as promising candidates for biomedical applications such as drug delivery [1,2,3]. Their high and modular porosity and internal amphiphilic microenvironment allow the incorporation of a variety of drug molecules with various physicochemical properties (hydrophobic, hydrophilic, and amphiphilic) reaching high drug loadings up to 20–70 wt% and yields close to 100% [4,5]. The drugs penetrated through the nanoMOFs accessible porosity, while versatile strategies were developed to functionalize the nanoMOFs’ external surfaces with cyclodextrins, (co)polymers, lipids, or silica shells [6,7]. The design and synthesis of MOFs for biomedical applications has attracted a growing interest.

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.